ProMIS Neurosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
ProMIS Neurosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.000.000.000.010.00
Cost of Revenue0.007.8816.094.632.50
Gross Profit0.00-7.88-16.09-4.63-2.50
Operating Expenses
Research & Development10.647.8814.474.950.00
Selling, General & Administrative6.195.585.283.311.95
Operating Expenses16.835.5823.208.261.95
Operating Income-16.83-13.46-23.20-8.25-4.44
Other Income/Expense
Interest Income0.000.000.000.000.00
Interest Expense0.08-0.200.28-0.420.00
Other Income/Expense19.611.25-5.42-0.580.00
Income
Income Before Tax2.78-13.21-18.06-9.24-4.44
Income Tax Expense0.000.000.000.000.00
Net Income2.78-13.21-18.06-9.79-4.44
Net Income - Continuous Operations2.78-13.21-18.06-9.790.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA2.86-13.44-17.53-9.33-4.43
EBIT2.86-13.46-17.78-9.37-4.44
Depreciation & Amortization0.000.020.010.050.01
Earnings Per Share
Basic EPS3.00-27.00-2.00-108.00-23.00
Diluted EPS3.00-27.00-2.00-108.00-23.00
Basic Shares Outstanding1.040.497.500.100.19
Diluted Shares Outstanding1.060.497.500.100.19